WG
HZNP

Winton Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Winton Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,617
Closed -$303K – 894
2023
Q3 		$303K Sell
2,617
-12
-0.5% -$1.29K 0.02% 547
2023
Q2 		$270K Sell
2,629
-8,275
-76% -$873K 0.02% 562
2023
Q1 		$1.19M Sell
10,904
-621
-5% -$68.6K 0.07% 381
2022
Q4 		$1.31M Sell
11,525
-2,080
-15% -$173K 0.09% 333
2022
Q3 		$842K Buy
13,605
+3,548
+35% +$248K 0.06% 470
2022
Q2 		$802K Buy
+10,057
New +$952K 0.04% 554
2022
Q1 		– Sell
-3,304
Closed -$356K – 1205
2021
Q4 		$356K Buy
3,304
+1,179
+55% +$129K 0.02% 778
2021
Q3 		$233K Buy
+2,125
New +$221K 0.01% 1188
2021
Q2 		– Sell
-3,213
Closed -$296K – 1565
2021
Q1 		$296K Buy
+3,213
New +$271K 0.02% 1151
2020
Q4 		– Sell
-24,591
Closed -$1.91M – 1622
2020
Q3 		$1.91M Sell
24,591
-21,434
-47% -$1.47M 0.06% 547
2020
Q2 		$2.56M Sell
46,025
-52,395
-53% -$2.24M 0.07% 527
2020
Q1 		$2.92M Sell
98,420
-91,434
-48% -$3.09M 0.08% 444
2019
Q4 		$6.87M Buy
189,854
+147,380
+347% +$4.52M 0.1% 363
2019
Q3 		$1.16M Buy
42,474
+19,400
+84% +$502K 0.01% 765
2019
Q2 		$555K Buy
+23,074
New +$585K 0.01% 636

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Winton Group's HZNP Position: Q4 2023 in Review

Winton Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,617 shares — an estimated $303K sold.

Winton Group first reported a position in HZNP in Q2 2019 and held it in 15 quarters. The position peaked at $6.87M in Q4 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Winton Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Winton Group sold 2,617 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $303K.
  • Winton Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 15 quarters.
  • Winton Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.87M in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Winton Group's 13F filing for Q4 2023, filed 12 Feb 2024.